Next-generation ALS drug silences inherited form of the disease in animal models
Monday, August 6, 2018 - 09:00
in Health & Medicine
NIH-funded researchers delayed signs of amyotrophic lateral sclerosis (ALS)in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1 (SOD1). The results, published in the Journal of Clinical Investigation, suggest the newer version of the drug may be effective at treating an inherited form of the disease caused by mutations […]